Recent WHO-commissioned systematic reviews have concluded with “high certainty” that exposure to radiofrequency electromagnetic fields (RF-EMF) increases cancer risk and reduces male fertility in experimental animals. We performed benchmark dose (BMD) analyses on experimental cancer data to estimate exposure levels associated with cancer risk of 1 × 10–5 (1 in 100,000). Due to the lack of an established non-linear mode of action for RF-EMF-induced tumor responses, we utilized linear low-dose extrapolation from 1% BMD values. In addition, we applied traditional uncertainty factors to the reported linear potency value of 0.03 per W/kg for male reproductive toxicity to derive health-protective exposure limits. The derived dose per hour (expressed as the specific absorption rate, SAR) at 1 × 10–5 cancer risk ranges from about 0.8 to 5 mW/kg. It should be noted that cancer risk increases with increasing time of exposure to RF-EMF. For protection of male fertility due to exposure to RF-EMF, the estimated SAR exposure limit was 3.3 to 10 mW/kg. These health protective whole-body exposure values are significantly lower than the current whole-body exposure limit value of 0.08 W/kg (80 mW/kg) established by ICNIRP and the FCC for the general public. For the general public, current regulatory limits to RF-EMF are 15- to 900-fold higher than our estimates of exposure levels associated with cancer risk of 1 × 10–5 (depending on the duration of daily exposure), and 8- to 24-fold higher than levels that are protective of male reproductive health. Thus, we strongly recommend an independent re-evaluation of RF-EMF exposure limits, integrating scientific data accumulated over the past 30 years and applying rigorous health-protective methodologies.
Melnick et al. (Fri,) studied this question.